Lifeist Wellness Inc. (LFST.V)
CAD 0.05
(-10.0%)
CAD 0.05
(-10.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.26 Million CAD | 285.59% |
| 2022 | 328.32 Thousand CAD | -40.8% |
| 2021 | 554.58 Thousand CAD | -26.58% |
| 2020 | 755.31 Thousand CAD | 3754.64% |
| 2019 | 19.59 Thousand CAD | -55.87% |
| 2018 | 44.4 Thousand CAD | -88.31% |
| 2017 | 379.92 Thousand CAD | 575.95% |
| 2016 | 56.2 Thousand CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.09 Million CAD | -6.95% |
| 2024 Q1 | 1.17 Million CAD | -7.07% |
| 2024 Q3 | 105.39 Thousand CAD | -69.46% |
| 2023 Q2 | 778.83 Thousand CAD | 191.54% |
| 2023 Q4 | 1.26 Million CAD | 77.9% |
| 2023 Q3 | 711.64 Thousand CAD | -8.63% |
| 2023 FY | 1.26 Million CAD | 285.59% |
| 2023 Q1 | 267.14 Thousand CAD | -18.63% |
| 2022 Q3 | 387.75 Thousand CAD | -12.95% |
| 2022 FY | 328.32 Thousand CAD | -40.8% |
| 2022 Q1 | 500.21 Thousand CAD | -9.8% |
| 2022 Q4 | 328.32 Thousand CAD | -15.33% |
| 2022 Q2 | 445.42 Thousand CAD | -10.95% |
| 2021 Q1 | 707.79 Thousand CAD | -6.29% |
| 2021 Q3 | 607.35 Thousand CAD | -7.78% |
| 2021 FY | 554.58 Thousand CAD | -26.58% |
| 2021 Q2 | 658.57 Thousand CAD | -6.95% |
| 2021 Q4 | 554.58 Thousand CAD | -8.69% |
| 2020 Q1 | 889.67 Thousand CAD | 4440.33% |
| 2020 FY | 755.31 Thousand CAD | 3754.64% |
| 2020 Q4 | 755.31 Thousand CAD | -5.76% |
| 2020 Q3 | 801.44 Thousand CAD | -5.29% |
| 2020 Q2 | 846.22 Thousand CAD | -4.88% |
| 2019 Q2 | 29.73 Thousand CAD | -14.27% |
| 2019 Q1 | 34.68 Thousand CAD | -55.98% |
| 2019 Q4 | 19.59 Thousand CAD | -17.24% |
| 2019 FY | 19.59 Thousand CAD | -55.87% |
| 2019 Q3 | 23.67 Thousand CAD | -20.36% |
| 2018 Q1 | 314.21 Thousand CAD | 1.01% |
| 2018 Q4 | 78.78 Thousand CAD | 77.43% |
| 2018 FY | 44.4 Thousand CAD | -88.31% |
| 2018 Q3 | 44.4 Thousand CAD | -26.55% |
| 2018 Q2 | 60.45 Thousand CAD | -80.76% |
| 2017 Q3 | 379.92 Thousand CAD | 6.42% |
| 2017 Q1 | 357.01 Thousand CAD | 0.0% |
| 2017 FY | 379.92 Thousand CAD | 575.95% |
| 2017 Q4 | 311.08 Thousand CAD | -18.12% |
| 2017 Q2 | 357.01 Thousand CAD | 0.0% |
| 2016 Q3 | 226.31 Thousand CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | 357.01 Thousand CAD | 57.75% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 FY | 56.2 Thousand CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q1 | - CAD | -100.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q4 | 120.93 Thousand CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.06 Million CAD | 74.999% |
| CanadaBis Capital Inc. | 7.3 Million CAD | 82.679% |
| Decibel Cannabis Company Inc. | 40.96 Million CAD | 96.909% |
| Delivra Health Brands Inc. | 2.02 Million CAD | 37.542% |
| Entourage Health Corp. | 161.58 Million CAD | 99.216% |
| Cannara Biotech Inc. | 45.78 Million CAD | 97.235% |
| Medicure Inc. | 544 Thousand CAD | -132.724% |
| PharmaCielo Ltd. | 18.3 Million CAD | 93.085% |
| Rubicon Organics Inc. | 10.25 Million CAD | 87.66% |
| BioSyent Inc. | 1.22 Million CAD | -3.683% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -3065.04% |